Patent 7122349 was granted and assigned to ZymoGenetics on October, 2006 by the United States Patent and Trademark Office.
The present invention provides two members of a new family of human proteins, designated as “Zven.” The Zven1 gene, which resides in human chromosome 3p21.1-3p14.3, is expressed in testicular tissue and peripheral blood lymphocytes.